Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series

OBJECTIVES: Anakinra is a selective IL-1 inhibitor, which has been used in the context of secondary haemophagocytic lymphohistiocytosis. Although usually given in the s.c. form, previous anecdotal reports have emphasized its utility when given i.v. Our aim is to report our experience on the benefici...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Kristina E N, Collas, Oliver, Lachmann, Helen, Singh, Animesh, Buckley, Jim, Bhagani, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454860/
https://www.ncbi.nlm.nih.gov/pubmed/32964179
http://dx.doi.org/10.1093/rap/rkaa040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454860/
https://www.ncbi.nlm.nih.gov/pubmed/32964179
http://dx.doi.org/10.1093/rap/rkaa040

Ejemplares similares